Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REVUMENIB vs RIFABUTIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REVUMENIB vs RIFABUTIN: Safety Overview

Metric REVUMENIB RIFABUTIN
Total FAERS Reports 371 1,586
Deaths Reported 49 158
Death Rate 13.2% 10.0%
Hospitalizations 93 502
Average Patient Age 46.4 yrs 53.2 yrs
% Female Patients 47.6% 53.1%
FDA Approval Date Nov 15, 2024 Dec 17, 2021
Manufacturer Syndax Pharmaceuticals, Inc. REMEDYREPACK INC.
Route ORAL ORAL
Marketing Status Prescription Prescription